Biotech company Clinical Genomics raises US$15 million round led by OneVentures
Clinical Genomics, a biotechnology company working across the United States and Australia, has closed a US$15 million ($19.7 million) round led by Sydney-based VC firm OneVentures. Dr Paul Kelly, partner at and managing director of OneVentures and former CEO of biotech company Gemini Genomics, will join the company’s board of directors.
You may also like
Ventured. Gained.
